QC
KURA icon

Quadrature Capital’s Kura Oncology KURA Stock Holding History

Quadrature Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.4K Buy
+12,227
New +$105K ﹤0.01% 1226
2025
Q4 		– Sell
-13,331
Closed -$118K – 1485
2025
Q3 		$118K Buy
+13,331
New +$95K ﹤0.01% 857

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrature Capital's KURA Position: Q1 2026 in Review

Quadrature Capital opened a new position in Kura Oncology (KURA) in Q1 2026: 12,227 shares worth $99.4K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in KURA as recently as Q3 2025.

Quadrature Capital first reported a position in KURA in Q3 2025 and has held it in 2 quarters since. The position peaked at $118K in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Quadrature Capital held 12,227 shares of Kura Oncology worth $99.4K as of Q1 2026.
  • Kura Oncology was a new Quadrature Capital position in Q1 2026.
  • Kura Oncology made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1226 holding.
  • Quadrature Capital first reported a position in Kura Oncology in Q3 2025 and has held it in 2 quarters since.
  • Quadrature Capital's Kura Oncology position peaked at $118K in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.